Startup investment platform Gongmyung Partners announced on the 25th that it will establish a 'medical specialized company builder' within April to foster and invest in technology-based startups in the medical, pharmaceutical, and advanced bio industries.
Considering the characteristics that require high level of expertise in the medical field, Gongmyeong Partners plans to form a separate specialized organization and operate an independent business with professionals in the industry. Through this, the goal is to build an 'incubating platform covering the entire tech-based startup bio industry' that supports the entire cycle from the early stages of startups, including technology verification, commercialization, investment linkage and investment attraction, and technology convergence linkage.
This company builder will focus on medical innovation in the fields of medical science and integrated oriental and western medicine that combine AI and deep tech technology. In addition, KAIST Professor Emeritus Dr. Kim Soo-yong and former Korea Venture Investment CEO Kim Hyung-ki will participate as co-investors and design a strategic fostering system that simultaneously considers both technological and market potential.
Resonance Partners has been recognized for its unique system of selecting investment targets and connecting actual capital and partnerships by utilizing the collective intelligence of investors through 'Resonance War'. This medical specialized company builder also plans to strengthen the connection with AI and deep tech-based startups discovered through Resonance War and lead innovation in the healthcare industry.
A representative of Gongmyung Partners said, “The rapid development of AI technology is causing fundamental changes in the medical system, and the future industry will lie in integrated medicine that is a fusion of medical science and Eastern and Western medicine,” adding, “This company builder will grow into a hub of the medical ecosystem that combines technology, capital, and expertise.”
- See more related articles
You must be logged in to post a comment.